Pfizer, Inc.(PFE) - Stock detail

Pfizer, Inc.

US
PFE
Pfizer Inc.(Listing date: 01/17/1944)

Pfizer Inc. was incorporated under the laws of Delaware on June 2, 1942. It is a research-based global biopharmaceutical company. Using science and global resources, the company brings therapies that extend and significantly improve people's lives through the discovery, development, manufacturing and distribution of healthcare products, including innovative medicines and vaccines. The company operates in both developed and emerging markets, committed to advancing health, prevention, treatment and cure for the world's most feared diseases of our time. It collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare services worldwide.

AI Technical AnalystHold
Rating4/10
Generated at:2026-03-04 16:37:11
Analysis period: 2025-12-05 to 2026-03-04 (90 calendar days, 60 trading days), data derived from daily OHLC and turnover behavior using volume-based proxy turnover calculation with 60-day window
Insight

Pfizer exhibits weak technical characteristics with price below key moving averages and negative momentum, but approaching oversold conditions with strong historical support around current levels.

Resistance
27.94
Support
24.83
Support and resistance are estimated from the latest 60 sessions.
Strategy
  • Short-term:HOLD for existing positions, WAIT for new entries; current technical setup suggests patience for better entry levels, wait for RSI_6 to drop below 30 for potential oversold bounce, monitor for consolidation above $26.38 support
  • Mid-term:Potential BUY opportunity if price holds above $26.09 support, MACD shows positive divergence, and volume increases on upward moves with price targets at $27.13 (conservative), $27.51 (moderate), or $27.89 (aggressive)
  • Long-term:Cautious approach recommended due to high historical stop-loss trigger rate and recent failed bullish setups; wait for confirmation of support holding at $26.09-$26.38 before considering new long positions with strict risk management protocols

Moving averages

MA 5
27.04
MA 20
27.13
MA 60
26.09
Price
26.62
AI Analysis
  • Mixed moving average configuration with MA_20 ($27.13) > MA_5 ($27.04) > MA_10 ($27.00) > MA_60 ($26.09)
  • Stock price ($26.62) is trading below all short-term moving averages (5, 10, 20-day)
  • Exponential Moving Averages show: EMA_20 ($26.92) > EMA_10 ($27.00) > EMA_5 ($26.90)
  • Price is below EMA_5, indicating short-term bearish pressure

Volume

Volume
30.79M
20D Avg
42.76M
Institution
-
Participation
-
AI Analysis
  • Recent volume (30,789,827 shares) below 60-day average
  • High volume spikes observed during major moves
  • December 16: 111.5M shares (significant selloff)
  • January 27: 75.6M shares (breakout)
  • February 3: 91.4M shares (correction)
  • Volume pattern suggests institutional participation in major price movements

MACD

MACD
0.19
Signal
0.30
Hist
-0.11
Trend
-
AI Analysis
  • MACD: 0.1900
  • MACD Signal: 0.3034
  • MACD Histogram: -0.1134 (negative)
  • Negative histogram indicates weakening momentum
  • Potential bearish crossover formation

Bollinger bands

Upper
27.89
Middle
27.13
Lower
26.38
Width
5.59%
AI Analysis
  • Upper Band: $27.89
  • Middle Band: $27.13
  • Lower Band: $26.38
  • Current price ($26.62) is near the lower band, suggesting potential oversold conditions
  • Band width indicates moderate volatility

RSI

RSI(14)
47.80
RSI(6)
37.04
Overbought
70+
Oversold
30-
AI Analysis
  • RSI (14-period): 47.80 (neutral territory)
  • RSI_6: 37.04 (approaching oversold conditions)
  • RSI configuration suggests neither overbought nor oversold conditions
  • Shows weakening momentum

KDJ

K
38.52
D
48.36
J
18.85
Trend
-
AI Analysis
  • KDJ: K (38.52) < D (48.36), J (18.85)
  • Bearish configuration

Chip distribution

How chip distribution helps you?
Chip distribution summary
  • Minority of positions are profitable with average cost at $27.00 and tight concentration around current price levels providing potential support.
  • Profit Ratio: 30.31% (minority of positions profitable)
  • Average Cost: $27.00 (current price below average cost)
  • 90% Cost Range: $25.58-$27.64 (moderate concentration: 3.87%)
  • 70% Cost Range: $26.26-$27.51 (tight concentration: 2.32%)
  • High concentration around current price levels suggests potential support
No chart data

Data is estimated based on turnover rate, high, low, open, and close prices. Profit ratios may vary significantly across different brokerage tools.